HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Jin Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2021Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming.
11/2019Morin attenuates oxidized low-density lipoprotein-mediated injury by inducing autophagy via activating AMPK signalling in HUVECs.
5/2012Apigenin, a plant-derived flavone, activates transient receptor potential vanilloid 4 cation channel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Jin Research Topics

Disease

134Neoplasms (Cancer)
05/2024 - 08/2009
37Breast Neoplasms (Breast Cancer)
01/2024 - 05/2006
19Inflammation (Inflammations)
11/2023 - 01/2011
14Infections
02/2024 - 03/2004
13Fibrosis (Cirrhosis)
01/2023 - 08/2014
12Carcinogenesis
01/2023 - 02/2014
9Wounds and Injuries (Trauma)
04/2024 - 01/2015
9Leukemia
04/2024 - 01/2013
9Neoplasm Metastasis (Metastasis)
01/2023 - 09/2013
8Multiple Myeloma
07/2023 - 02/2016
7Diabetes Mellitus
03/2019 - 04/2013
6Thyroid Neoplasms (Thyroid Cancer)
01/2024 - 01/2019
6Triple Negative Breast Neoplasms
02/2023 - 04/2012
6Ovarian Neoplasms (Ovarian Cancer)
11/2022 - 09/2013
6Non-alcoholic Fatty Liver Disease
11/2021 - 04/2019
5Lung Neoplasms (Lung Cancer)
04/2024 - 05/2018
5COVID-19
03/2024 - 11/2020
5Hepatocellular Carcinoma (Hepatoma)
01/2023 - 02/2016
5Necrosis
01/2023 - 11/2018
5Fatty Liver
01/2021 - 01/2019
5Melanoma (Melanoma, Malignant)
01/2020 - 09/2008
4Pain (Aches)
04/2024 - 05/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 02/2015
4Alzheimer Disease (Alzheimer's Disease)
11/2023 - 01/2021
4Hypoxia (Hypoxemia)
02/2023 - 03/2015
4Ureteral Obstruction
01/2023 - 12/2020
4Mitochondrial Diseases (Mitochondrial Disease)
07/2022 - 01/2017
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2015
4Catalepsy
01/2021 - 11/2011
4Hyperglycemia
01/2021 - 01/2016
4Colonic Neoplasms (Colon Cancer)
08/2018 - 01/2014
3Lymphopenia (Lymphocytopenia)
03/2024 - 11/2020
3Stomach Neoplasms (Stomach Cancer)
02/2024 - 01/2018
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2024 - 01/2021
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 01/2019
3Heart Failure
03/2023 - 01/2014
3Prostatic Neoplasms (Prostate Cancer)
10/2022 - 01/2014
3Cicatrix (Scar)
07/2022 - 12/2018
3Insulin Resistance
01/2021 - 03/2019

Drug/Important Bio-Agent (IBA)

52Proteins (Proteins, Gene)FDA Link
03/2024 - 05/2006
20Doxorubicin (Adriamycin)FDA LinkGeneric
10/2023 - 10/2012
15ChromatinIBA
02/2024 - 09/2011
14Histones (Histone)IBA
04/2024 - 08/2010
13Lysine (L-Lysine)FDA Link
04/2024 - 08/2010
13snake venom protein C activatorIBA
03/2024 - 01/2021
12Biomarkers (Surrogate Marker)IBA
03/2024 - 04/2014
12EnzymesIBA
12/2023 - 04/2018
11Proteolysis Targeting ChimeraIBA
03/2024 - 01/2021
11Phosphotransferases (Kinase)IBA
01/2023 - 09/2008
10MethyltransferasesIBA
04/2024 - 01/2011
10Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 09/2013
9CytokinesIBA
10/2023 - 01/2014
8Polycomb Repressive Complex 2IBA
07/2023 - 01/2015
8Polychlorinated Biphenyls (PCBs)IBA
01/2021 - 01/2019
7RNA (Ribonucleic Acid)IBA
12/2023 - 08/2017
7LigandsIBA
01/2022 - 08/2012
7Transcription Factors (Transcription Factor)IBA
01/2022 - 05/2006
7Transient Receptor Potential ChannelsIBA
10/2017 - 10/2012
6Histone MethyltransferasesIBA
03/2024 - 01/2014
6CateninsIBA
01/2023 - 05/2015
6MicroRNAs (MicroRNA)IBA
02/2022 - 05/2014
6AnthracyclinesIBA
10/2018 - 10/2014
5ProteomeIBA
03/2024 - 07/2020
5Enhancer of Zeste Homolog 2 ProteinIBA
05/2023 - 01/2015
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2014
5Arginine (L-Arginine)FDA Link
01/2021 - 01/2011
5taxaneIBA
10/2018 - 10/2014
5Tacrolimus (Prograf)FDA LinkGeneric
01/2018 - 01/2016
5Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2015 - 10/2012
4Therapeutic UsesIBA
01/2024 - 08/2019
4Oncogene Proteins (Oncogene Protein)IBA
10/2023 - 01/2022
4Antipsychotic Agents (Antipsychotics)IBA
10/2023 - 11/2011
4Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
08/2023 - 01/2021
4UNC1999IBA
05/2023 - 01/2015
4ProdrugsIBA
02/2023 - 01/2018
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2017
4Small Interfering RNA (siRNA)IBA
01/2022 - 01/2017
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2015
4ElementsIBA
01/2021 - 07/2016
4Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021 - 12/2011
4graphene oxideIBA
01/2021 - 01/2019
4Phosphatidylinositols (Phosphatidylinositol)IBA
07/2019 - 05/2014
3N-methyladenosineIBA
02/2024 - 05/2022
3AntibodiesIBA
12/2023 - 04/2020
3Dopamine (Intropin)FDA LinkGeneric
11/2023 - 12/2016
3Proteasome Endopeptidase Complex (Proteasome)IBA
10/2023 - 08/2017
3Photosensitizing Agents (Photosensitizers)IBA
02/2023 - 02/2022
3AntigensIBA
01/2023 - 05/2006
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2022 - 01/2019
3Lapatinib (GW572016)FDA Link
01/2022 - 10/2012
3DioxinsIBA
12/2021 - 04/2019
3Antiviral Agents (Antivirals)IBA
10/2021 - 03/2004

Therapy/Procedure

67Therapeutics
04/2024 - 04/2012
25Drug Therapy (Chemotherapy)
02/2024 - 10/2012
5Thyroidectomy
03/2022 - 01/2015
4Oral Administration
11/2023 - 01/2015
4Neoadjuvant Therapy
10/2022 - 04/2016
4Transplantation
01/2021 - 01/2016
3Immunotherapy
05/2024 - 01/2020
3Radiotherapy
02/2024 - 07/2015